Substrate AI: Vendor Deep Dive

The Substrate AI story is worth close reading precisely because it sits at the intersection of two forces reshaping RCM in 2026: the broad adoption of agentic AI — autonomous software that navigates payer portals and completes multi-step tasks without human supervision — and a market that has grown deeply skeptical of vendor promises after a decade of "AI-powered" tools that were, in practice, glorified rules engines. The question for billing directors evaluating Substrate isn't whether agentic AI is real. It is. The question is whether this particular platform delivers durable operational value at the price and implementation speed it advertises.

The Landscape: Prior Auth And Claims In 2026

The administrative burden of payer interaction has reached a level that is structurally unsustainable for most provider organizations. The American Medical Association's 2024 Prior Authorization Physician Survey found that 94% of physicians report prior authorization delays care delivery, and the downstream billing consequence — denied claims, delayed cash, and write-offs — compounds directly into revenue cycle performance metrics every billing director is accountable for. Claim status follow-up, the unglamorous workhorse of the AR department, typically requires staff to log into dozens of separate payer portals, navigate inconsistent interfaces, and manually document status updates into the practice management system. At any organization processing more than 5,000 claims per month, this is a multi-FTE function that produces no incremental revenue and exists purely as a tax on administrative complexity.

The payer friction dynamic is not accidental. As Ayo Omojola, Substrate AI's representative, noted in a 2026 podcast interview with Patient Care Marketing Pros, payers deliberately create friction to delay or avoid payments — and the organizations best positioned to absorb that friction are large payers with sophisticated administrative operations, not the billing teams at community hospitals and urgent care groups trying to stay current on AR. This asymmetry is the market problem Substrate is building against. The company's explicit positioning — agentic AI that handles claim status, appeals, and eligibility across 3,500+ payers — frames the product as a structural equalizer, not just a productivity tool.

The broader market context matters for evaluating any new entrant here. RCM technology is not a greenfield opportunity. It is a crowded space with entrenched competitors including Waystar, Availity, Change Healthcare (now part of Optum), and a wave of AI-native challengers like Adonis, Athelas, and Infinx. Each of these players has made investments in automation, and each has existing relationships with the provider organizations Substrate is targeting. A new vendor claiming 48-hour go-live and hands-free automation is making an extraordinary claim in a category where implementation timelines measured in months are the norm and where broken integrations have burned many organizations.

How The Platform Works

Substrate ARC operates through what the company describes as autonomous AI agents — software entities that execute multi-step workflows across payer portals and clearinghouses without requiring a human to complete each step. The core agent categories publicly documented are the Claim Status Agent, eligibility verification, and appeals processing. The Claim Status Agent, which reached general availability in April 2026, is specifically described as the industry's first AI-native solution for claims monitoring — a distinction that separates it from robotic process automation (RPA) tools that mimic human clicks on fixed portal structures but break when payer interfaces change. True AI-native agents use machine learning and natural language processing to adapt to interface variation, which is the persistent failure mode of legacy RPA in RCM.

The 48-hour go-live promise is the headline deployment claim, and it is worth unpacking what that actually means operationally. Substrate's framing — "no IT project" — suggests the platform connects via existing clearinghouse relationships and payer portal credentials rather than requiring deep EHR integration or custom API development. This is consistent with how many agentic AI tools in RCM function: they operate at the portal layer, not the database layer, which dramatically reduces IT dependency but also sets the ceiling on what data they can access and write back. Billing directors should ask specifically whether Substrate writes status updates back to their practice management system automatically or requires a manual reconciliation step. The answer determines whether the "hands-free" promise extends end-to-end or only covers the payer-facing portion of the workflow.

The platform also includes what Substrate describes as a "billing copilot" for productivity enhancement and real-time agent tracking — giving supervisors visibility into what agents are doing at any given moment. This is a meaningful operational feature. One of the legitimate concerns about fully autonomous agents in RCM is auditability: when a denial goes unworked or a claim status update is incorrect, billing managers need a clear log to reconstruct what happened and why. Real-time tracking and agent activity logs are table-stakes requirements for any agentic platform operating in a HIPAA-regulated environment, and their inclusion in Substrate's feature set is a positive signal.

Where It Delivers Value

The highest-value use case for Substrate in the current market is clearly claim status follow-up for organizations with high-volume, multi-payer environments — specifically urgent care groups, independent physician associations, and rural hospitals where billing staff are stretched thin and the volume of payer touchpoints exceeds what a human team can efficiently manage. The 4x volume handling testimonial cited on Substrate's website is the most concrete performance data available. Four times the throughput with the same team, if reproducible at scale, represents a fundamental change in the economics of the AR department — it either allows organizations to absorb growth without adding headcount or allows existing staff to redirect time toward higher-complexity denials work that genuinely requires human judgment.

Appeals automation is the second high-value use case, and arguably the one with greater revenue impact per transaction. A successfully overturned denial on a complex procedure claim can recover hundreds to thousands of dollars per case — an order of magnitude more value than routine claim status. The challenge with appeals automation is that appeals require clinical and contractual reasoning, not just portal navigation. Substrate's marketing references appeals as an agent capability, but billing directors should probe specifically for: which denial reason codes Substrate's appeals agents handle, what the overturn rate is relative to human-worked appeals, and whether the appeals content is pre-templated or dynamically generated based on the specific denial rationale. The answers will reveal whether this is genuine appeals intelligence or automated letter generation. Note also that payer-specific appeal filing deadlines — commonly 90 to 180 days from the remittance date for commercial payers, and 120 days from the Medicare Remittance Advice date for Medicare claims under 42 CFR §405.942 — are non-negotiable; any appeals automation tool must track and respect these windows without exception.

Eligibility verification is the third core use case and the one with the broadest applicability across care settings. Real-time eligibility checks before service delivery directly reduce front-end denials, which account for a substantial portion of total denial volume at most organizations. The MGMA's 2023 Stat Poll found that eligibility and authorization issues are consistently the leading root cause of front-end denials, routinely cited by more than 40% of medical group respondents. Substrate's eligibility agent operating across 3,500+ payers addresses one of the real pain points in eligibility automation: coverage at regional and secondary payers where clearinghouse-based eligibility tools have gaps. For multi-specialty groups and federally qualified health centers dealing with a complex payer mix, this breadth of coverage is a genuine differentiator.

Competitive Positioning

Substrate AI's most direct competitive frame, as reflected in its own resources page, is against RCM BPO outsourcing — the offshore or nearshore billing service model that remains the dominant alternative for organizations that lack internal automation capability. The comparison is strategically sharp because the BPO model has well-documented problems that any billing director has lived: loss of PHI control, inconsistent staff quality, communication lag, and a cost structure that scales linearly with volume. An AI agent platform, by contrast, scales horizontally without proportional cost increase, maintains PHI within a defined technical boundary, and operates continuously without shift constraints.

The resources page also directly names Adonis and Athelas as comparison points — a signal that Substrate sees the AI-native RCM space, not legacy vendors, as its competitive set. Adonis focuses heavily on denial prevention analytics and EHR-native integration. Athelas has built a strong position in physician practice revenue cycle with a broader suite including patient payments and practice management. Substrate's differentiation from these peers appears to be the depth of agentic autonomy — agents that actually execute workflows rather than surfacing recommendations for humans to act on — and the speed of deployment. Where Adonis and Athelas require more extensive onboarding and configuration, Substrate's 48-hour promise is a direct counter-positioning move.

Against larger incumbents like Waystar and Availity, Substrate is not competing on breadth of clearinghouse functionality or payer contract intelligence — it is competing on execution automation. This is the right strategic choice for an early-stage company: don't try to replicate the full functionality of a clearinghouse, build the agent layer that makes the clearinghouse more useful. Whether that positioning is sustainable as larger vendors build their own agentic capabilities is the central strategic question for any buyer making a multi-year commitment.

The 7 Powers Lens: Substrate Ai Strategic Durability

Evaluating any RCM technology vendor through the lens of Hamilton Helmer's 7 Powers framework gives billing directors and VPs of Revenue Cycle a disciplined structure for assessing not just whether a product works today, but whether the vendor will still be a viable, differentiated partner in three to five years. In a market where consolidation is constant — Waystar's public offering, Change Healthcare's absorption into Optum, and ongoing private equity rollups of RCM technology — choosing a vendor with genuine strategic durability protects against the scenario where your chosen partner gets acquired, pivots, or loses its edge to a better-capitalized competitor. For Substrate AI specifically, this analysis is particularly important given its early stage.

Power	Strength	Assessment
Scale Economies	Weak	Early-stage revenue base limits cost-per-unit advantages; no evidence of data center or infrastructure scale that creates meaningful per-customer cost reduction yet
Network Economies	Emerging	3,500+ payer connections create a network that becomes more valuable with each additional payer integration; value grows as coverage breadth increases
Counter-Positioning	Strong	Agent-based autonomous execution is structurally difficult for BPO incumbents to replicate without cannibalizing their existing labor model
Switching Costs	Moderate	Workflow embedding and staff process redesign around AI agents creates meaningful but not extraordinary switching friction
Branding	Weak	Brand recognition in RCM is nascent; no established reputation comparable to Waystar or Change Healthcare
Cornered Resource	Weak	No publicly documented proprietary data asset, exclusive payer API relationships, or unique talent advantage that competitors cannot access
Process Power	Emerging	Agentic workflow design and rapid deployment methodology may constitute process learning advantages as the team accumulates implementation experience

Counter-Positioning as the Core Moat

Counter-positioning is Substrate's most defensible power, and it operates against the BPO and offshore billing incumbent specifically. The traditional RCM outsourcing model is structurally committed to a labor-cost arbitrage approach — it sells the value of human expertise at lower per-hour cost. Deploying agentic AI to replace that labor model would directly undermine the BPO's revenue per engagement, which means the largest BPO incumbents face a genuine innovator's dilemma: cannibalize their existing business to compete, or cede the automation segment to new entrants. Substrate benefits from this dynamic regardless of how good any individual competitor's technology is. The incumbents are structurally inhibited from responding aggressively, which buys Substrate time to build customer relationships and deepen its network coverage.

Biggest Strategic Vulnerability

The most significant vulnerability in Substrate's strategic position is the absence of a cornered resource — specifically, a proprietary payer intelligence data asset. As more AI agents interact with payer portals across thousands of claims, the organization that aggregates that interaction data into a payer behavior model (which payers delay by what average duration, which denial reason codes are most successfully appealed with what clinical language, which portals require what navigation adaptations) accumulates a compounding advantage. Substrate may be building this asset, but it is not publicly documented, and larger competitors like Waystar have years of transactional data that could power superior payer intelligence if they build the agentic execution layer. The window for Substrate to establish a proprietary data moat is measured in months, not years.

Switching Cost Reality for Buyers

Switching costs for Substrate customers are moderate in technical terms but meaningful in operational terms. Because the platform operates at the portal layer rather than requiring deep EHR integration, disconnecting Substrate is technically simpler than migrating away from an EHR-embedded billing module. However, the operational switching cost is real: staff workflows redesigned around AI agent output, reporting structures built on Substrate's dashboards, and institutional knowledge about how to configure and supervise the agents all create friction that makes switching non-trivial. Buyers should negotiate contract terms accordingly — annual renewal options and data export rights should be standard in any agreement, and the contract should specify what happens to workflow configurations and historical agent activity logs if the relationship terminates.

Implementation Experience

Substrate's 48-hour go-live claim is the most operationally consequential promise the company makes, and it deserves direct examination. The mechanism is payer portal credential-based access — Substrate agents use the organization's existing payer portal credentials to navigate and execute tasks, which means no API negotiation with payers and no clearinghouse contract amendment. This approach has precedent in the RPA world and is a legitimate pathway to fast deployment. The risk is portal-level access dependency: if a payer changes its portal interface, implements CAPTCHA updates, or revokes automation access, the agent stops working until the platform updates its navigation logic. Billing directors should ask Substrate specifically about their portal update response time — how quickly do agents recover after a payer portal change breaks the workflow.

One additional compliance consideration at the portal access layer: several large commercial payers, including UnitedHealthcare and Cigna, include provisions in their portal terms of service that restrict or prohibit automated access using provider credentials. Billing directors should confirm with Substrate how the platform addresses these terms-of-service constraints and whether payer-specific access agreements are required for certain portals before go-live.

The platform's real-time agent tracking feature is operationally important for the implementation phase specifically. In the first 30 to 60 days, billing supervisors need to validate that agents are returning accurate claim status information, not just returning information quickly. A high-speed agent that returns incorrect status data creates downstream errors that are expensive to correct — misprioritized AR, failed appeals timing, and incorrect patient balance calculations. Build a parallel-run validation period into the implementation plan: run Substrate agents simultaneously with manual staff on a sample of claims and compare results before fully transitioning volume to the platform.

Pricing And Roi Analysis

Substrate AI's pricing model, based on publicly available information, follows a usage-based structure — consistent with the company's cloud-infrastructure positioning and the SaaS norms of the agentic AI space. The company offers $100 in free credits as a starting point, which effectively enables a proof-of-concept run without financial commitment. For organizations evaluating the platform, this is the appropriate entry point: use the free credit allocation to process a defined set of claims through the status agent, measure the accuracy and speed of response against your current manual baseline, and build a real ROI calculation from actual performance data rather than vendor projections.

The ROI case for Substrate, constructed conservatively, rests on two variables: FTE cost avoided and denial recovery rate improvement. If the 4x volume claim holds — the same team handles four times the claim volume — the math for a mid-sized billing department processing 10,000 claims per month is straightforward. An organization currently staffing four FTEs on claim status follow-up at a fully loaded cost of $55,000 to $65,000 per FTE annually would, at 4x capacity, either eliminate the need for three of those positions (roughly $165,000 to $195,000 in annual labor savings) or redirect them to appeals and denial management work with higher per-transaction revenue impact. Against a usage-based platform fee, the breakeven threshold is achievable within months at this scale. These FTE cost figures are consistent with 2025 MGMA compensation data for billing and collections staff in non-supervisory roles, which places median total compensation in the $45,000 to $58,000 range, with fully loaded costs (benefits, payroll taxes, overhead) typically running 25 to 35 percent above base.

Scenario	Current FTE Cost	Agent-Enabled Capacity	Annual Labor Savings
Small Group (5,000 claims/mo)	$110,000 (2 FTE)	4x volume capacity	$55,000–$65,000 redirected
Mid-Size Group (10,000 claims/mo)	$220,000 (4 FTE)	4x volume capacity	$165,000–$195,000 avoided or redirected
Large Group (25,000 claims/mo)	$550,000 (10 FTE)	4x volume capacity	$412,000–$487,000 structural savings

What To Do Monday Morning

1. 1
   Run a 30-Day Pilot on Claim Status, Scoped to a Single Payer

   Contact Substrate AI directly through substrateai.com and request access to the free credit tier for a controlled pilot. Scope the pilot to claim status follow-up with a single high-volume commercial payer — one where your team currently spends identifiable FTE time and where you have clean baseline data on average days to status response and staff hours per 100 claims. A single-payer scope lets you isolate the agent's performance from payer variability and gives you a clean apples-to-apples comparison at the end of 30 days. Document your baseline before Day 1, not retrospectively.

2. 2
   Audit Your Current Claim Status FTE Load

   Before any vendor conversation, pull 90 days of time-study data or estimate from your billing manager how many FTE hours per week are consumed by claim status follow-up, portal logins, and manual status documentation. This number is the denominator of your ROI calculation. If you don't have formal time-study data, have two billing staff log their activities in 15-minute increments for two weeks — the exercise itself will surface inefficiencies beyond the Substrate evaluation and gives you defensible data for any CFO conversation about automation investment.

3. 3
   Require a BAA and Data Flow Diagram Before Signing Anything

   Substrate's own resources explicitly position